Pioneering breath
analysis for over 8 years
PNOĒ was founded in 2016 with the goal of making breath analysis accessible to all. Since then it has developed the world’s first lab-grade cardio-metabolic analyzer for the mass market along with an
entire ecosystem that powers holistic approach to health.
Meet the founders
PNOĒ was founded by Apostolos Atsalakis and Panos Papadiamantis, two engineers from Greece who embarked on a mission to make breath analysis accessible to all.
The idea originated during Apostolos’ PhD and after almost 2 years of research and development evolved into PNOĒ’s first commercial breath analysis system.
About PNOĒ
Today PNOĒ is one of the few companies globally with the know how to develop and capabilities to develop lab-grade cardio-metabolic analyzers.
Our growing team now comprises expertise in the fields of hardware development and manufacturing software development, as well as scientific study design and implementation.
Throughout its journey PNOĒ became part of several organizations and entrepreneurial groups of international acclaim including the Y Combinator, Endeavor, and has also been recognized by the Financial Times as the one of the fastest growing companies in the US in 2023 and 2024.